Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - kalcijev klorid dihidrat; magnezijev klorid heksahidrat; natrijev acetat trihidrat; želatina, sukcinilirana; natrijev klorid; kalijev klorid - raztopina za infundiranje - kalcijev klorid dihidrat 0,15 g / 1000 ml  magnezijev klorid heksahidrat0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; magnezijev klorid heksahidrat 0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; natrijev acetat trihidrat 3,27 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; želatina, sukcinilirana 40 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; natrijev klorid 5,55 g / 1000 ml  kalijev klorid0,3 g / 1000 ml; kalijev klorid 0,3 g / 1000 ml - derivati želatine

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - kalcijev klorid dihidrat; kalijev klorid; magnezijev klorid heksahidrat; natrijev acetat trihidrat; natrijev klorid; želatina, sukcinilirana - raztopina za infundiranje - kalcijev klorid dihidrat 0,15 g / 1000 ml  kalijev klorid0,3 g / 1000 ml  magnezijev klorid heksahidrat0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; kalijev klorid 0,3 g / 1000 ml  magnezijev klorid heksahidrat0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; magnezijev klorid heksahidrat 0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; natrijev acetat trihidrat 3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; natrijev klorid 5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; želatina, sukcinilirana 40 g / 1000 ml - derivati želatine

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - kalcijev klorid dihidrat; kalijev klorid; magnezijev klorid heksahidrat; natrijev acetat trihidrat; natrijev klorid; želatina, sukcinilirana - raztopina za infundiranje - kalcijev klorid dihidrat 0,15 g / 1000 ml  kalijev klorid0,3 g / 1000 ml  magnezijev klorid heksahidrat0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; kalijev klorid 0,3 g / 1000 ml  magnezijev klorid heksahidrat0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; magnezijev klorid heksahidrat 0,2 g / 1000 ml  natrijev acetat trihidrat3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; natrijev acetat trihidrat 3,27 g / 1000 ml  natrijev klorid5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; natrijev klorid 5,55 g / 1000 ml  želatina, sukcinilirana40 g / 1000 ml; želatina, sukcinilirana 40 g / 1000 ml - derivati želatine

Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -

Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ciclesonide - dihalni sistem, druga zdravila za obstruktivne pljučne bolezni, inhalants - konji - za lajšanje kliničnih znakov hude konjskega astme (prej znan kot periodično obstrukcijo dihalnih poti – (rao), poletno pašo povezane periodično obstrukcijo dihalnih poti – (spa-rao)).

Evropska unija - slovenščina - EMA (European Medicines Agency)

novo nordisk a/s - semaglutid - obesity; overweight - preparati za zaščito proti sončenju, prehrambeni izdelki - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Evropska unija - slovenščina - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.